Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines (Q28206870)

1

0 references

Shinichi Toyooka

2

0 references

Riichiroh Maruyama

4

0 references

Kiyomi O Toyooka

5

0 references

Charles F Timmons

6

0 references

Gail E Tomlinson

7

0 references

Domenico Mastrangelo

8

0 references

Robert J Hay

9

0 references

John D Minna

10

0 references

Adi F Gazdar

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

11

0 references

language of work or name

English

0 references

publication date

20 June 2002

0 references

published in

Oncogene

0 references

volume

21

0 references

issue

27

0 references

page(s)

4345-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Molecular genetic aspects of solid tumors in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

The H-cadherin (CDH13) gene is inactivated in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

7 January 2021

Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

7 January 2021

Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205446

7 January 2021